Clinical Trial Update: Bioequivalence of Single Dose Phenylephrine Extended Release Tablets and Phenylephrine HCl Immediate Release Tablets Dosed Every Four Hours (P08340)(COMPLETED) [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating bioequivalence between a single-dose extended-release phenylephrine tablet and an immediate-release phenylephrine HCl tablet given ev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasal Congestion

Drugs mentioned

• Phenylephrine Extended-Release Tablet (phenylephrine)
• Phenylephrine HCl Immediate-Release Tablet (phenylephrine)

Snippet

Sponsor: Bayer | Conditions: Nasal Congestion | Phase 1 | Status: COMPLETED